Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole XL Open-Label Extension in Parkinson's Disease
NCT00632736Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2004
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ropinirole in Parkinson's disease (PD), sponsored by GSK. Started Feb 2004; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00632736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632736.